Fritextsökning
Innehållstyper
-
Engelsk biobank öppnas för forskning
Inriktas speciellt på hjärt-kärlsjukdomar, cancer och diabetes.
-
Brittisk forskning hamnar efter
Mindre finansiering får Storbritanniens forskning att tappa mark, enligt organisationen Case.
-
Plenadren säljs vidare
Duocort Pharmas preparat tas upp i irländska Shires portfölj med specialläkemedel.
-
Opinion: Where do all the cool Swedish life science companies go?
It’s puzzling why Swedish life science companies hardly get a mention alongside Spotify, Skype, Klarna, King, iZettle, and other cool, innovative and successful...
-
Nya standarder för effektiv utveckling
- För effektivare läkemedelsutveckling
-
Astra-nej får blandat mottagande av aktieägarna
Efter att Astrazenecas ledning tackat nej till Pfizers budpropåer för fjärde gången har missnöje väckts hos några av aktieägarna.
-
Hey Kurt Berndt...
... who is starting up a research center for youths in Saltsjöbaden.
-
New CEO to Promedvi
Sigrun Axelsson has taken on the leadership of the Lund-based medtech company.
-
Early stage research and low turnaround dominates
Nordic science parks are full of advanced research performed by small companies but little research is done in later stages. Only a couple of the best performer...
-
Medtech giant separates
Due to the global economic situation, the medtech companies Q-Med and the Palomar Medical Technologies has terminated its international agreement.
-
Pfizer höjer budet på Astrazeneca
Pfizer beskriver det nya budet, på 607 kronor aktien, som det "sista", men räknar inte med att Astrazenecas styrelse kommer att acceptera erbjudandet.
-
Budar på Sobi
Läkemedelsbolaget mottog nyligen ett bud från en ospecificerad budgivare.
-
Forskare får hjälp att fatta beslut
En ny mjukvara ska samla in och tolka resultat från kliniska prövningar.
-
Trio goes in for high tech medicines
The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.
-
Bring talent to those in need
Ho ho ho, Christmas time is here again. So get busy decking the halls, perhaps not with assorted greenery, but with something of a more lasting value.
-
New NO product reduces diabetic pain
The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.
-
Mathematician new dean at DTU
On January 1st the Technical University of Denmark, DTU, got a new dean, recruited from the department of Mathematics.
-
Ozzy Osbournes DNA under lupp
Ett amerikanskt företag ska granska Ozzy Osbournes DNA för att ta reda på hur han kan ha överlevt 40 år av drog- och alkoholmissbruk.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Almost 150 will leave Coloplast
The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.
-
Ryssland satsar på klinisk forskning
Ryska Quintiles och statlig kapitalfond samarbetar i ny hälsoplan som ska sätta landets kliniska forskning på världskartan.
-
Harmony prevents dementia
People who are active, outgoing and relaxed may be less likely to develop dementia, according to a new study from Karolinska Institutet.
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
High hopes for future partnering - the solution for struggling fairs
Business fairs are struggling but the concept of partnering is hotter than ever. By using social media, participants can prepare themselves for the perfect meeting.
BREAKING